Pyxis Oncology (PYXS) Short Interest Ratio & Short Volume → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free PYXS Stock Alerts $4.15 -0.02 (-0.48%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pyxis Oncology Short Interest DataCurrent Short Volume1,850,000 sharesPrevious Short Volume2,210,000 sharesChange Vs. Previous Month-16.29%Dollar Volume Sold Short$8.23 millionShort Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares58,890,000 sharesFloat Size46,860,000 sharesShort Percent of Float3.95%Today's Trading Volume257,383 sharesAverage Trading Volume410,889 sharesToday's Volume Vs. Average63% Short Selling Pyxis Oncology ? Sign up to receive the latest short interest report for Pyxis Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPYXS Short Interest Over TimePYXS Days to Cover Over TimePYXS Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Pyxis Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,850,000 shares $8.23 million -16.3%4.0%2.5 $4.45 4/15/20242,210,000 shares $10.48 million -18.2%4.8%2.4 $4.74 3/31/20242,700,000 shares $11.50 million +65.6%6.9%3.1 $4.26 3/15/20241,630,000 shares $8.35 million +21.6%5.3%2.1 $5.12 2/29/20241,340,000 shares $8.52 million +4.7%4.4%2 $6.36 2/15/20241,280,000 shares $7.16 million +63.1%4.2%2.2 $5.59 Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024784,600 shares $2.99 million +28.4%2.6%2 $3.81 1/15/2024611,100 shares $1.44 million -3.6%2.0%3.2 $2.35 12/31/2023634,000 shares $1.14 million -6.0%2.1%4.4 $1.80 12/15/2023674,600 shares $1.17 million -9.6%2.2%5.3 $1.73 11/30/2023745,800 shares $1.19 million -6.9%2.5%5.8 $1.59 11/15/2023801,100 shares $1.22 million +1.1%2.7%6.4 $1.52 10/31/2023792,500 shares $1.32 million -9.7%2.6%5.9 $1.67 10/15/2023877,300 shares $1.75 million -6.9%2.9%5.8 $2.00 9/30/2023942,400 shares $1.88 million +3.6%3.1%5.3 $1.99 9/15/2023910,100 shares $1.92 million -5.1%3.0%4.2 $2.11 8/31/2023958,600 shares $2.09 million -15.2%3.0%4 $2.18 8/15/20231,130,000 shares $2.76 million -2.6%3.9%3.9 $2.44 7/31/20231,160,000 shares $2.99 million -4.1%4.3%3.1 $2.58 7/15/20231,210,000 shares $3.21 million -60.2%4.5%2.7 $2.65 6/30/20233,040,000 shares $7.78 million -3.5%11.3%4.9 $2.56 6/15/20233,150,000 shares $9.51 million No Change11.7%0.8 $3.02 5/31/20233,150,000 shares $10.14 million +2.6%11.9%0.8 $3.22 5/15/20233,070,000 shares $11.45 million -14.7%11.6%0.8 $3.73 4/30/20233,600,000 shares $10.62 million -23.7%17.9%1 $2.95 4/15/20234,720,000 shares $16.38 million -2.7%23.4%1.3 $3.47 3/31/20234,850,000 shares $19.45 million +5,962.5%25.0%1.4 $4.01 3/15/202380,000 shares $160,800.00 -52.3%0.4%0.5 $2.01 2/28/2023167,700 shares $380,679.00 +49.6%0.8%1.4 $2.27 2/15/2023112,100 shares $173,755.00 -88.5%0.6%0.7 $1.55 1/31/2023973,800 shares $1.52 million +2.8%4.8%5.4 $1.56 1/15/2023947,200 shares $1.45 million +14.7%4.7%5.9 $1.53 12/30/2022826,200 shares $1.11 million +35.7%4.1%4.8 $1.34 12/15/2022609,000 shares $694,260.00 +110.1%3.0%3.7 $1.14 11/30/2022289,800 shares $420,210.00 +80.5%1.4%2 $1.45 11/15/2022160,600 shares $234,476.00 +286.1%0.8%2.1 $1.46 10/31/202241,600 shares $77,792.00 -54.8%0.2%0.7 $1.87 10/15/202292,100 shares $155,649.00 -13.3%0.5%2 $1.69 9/30/2022106,200 shares $209,214.00 -3.1%0.5%2.4 $1.97 9/15/2022109,600 shares $260,848.00 +34.6%0.5%1.1 $2.38Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad)Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks."And these will be the biggest winners PYXS Short Interest - Frequently Asked Questions What is Pyxis Oncology's current short interest? Short interest is the volume of Pyxis Oncology shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,850,000 shares of PYXS short. 3.95% of Pyxis Oncology's shares are currently sold short. Learn More on Pyxis Oncology's current short interest. What is a good short interest ratio for Pyxis Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PYXS shares currently have a short interest ratio of 2.0. Learn More on Pyxis Oncology's short interest ratio. What is a good short interest percentage for Pyxis Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.95% of Pyxis Oncology's floating shares are currently sold short. Is Pyxis Oncology's short interest increasing or decreasing? Pyxis Oncology saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 1,850,000 shares, a drop of 16.3% from the previous total of 2,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pyxis Oncology's float size? Pyxis Oncology currently has issued a total of 58,890,000 shares. Some of Pyxis Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pyxis Oncology currently has a public float of 46,860,000 shares. How does Pyxis Oncology's short interest compare to its competitors? 3.95% of Pyxis Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Pyxis Oncology: Aldeyra Therapeutics, Inc (4.03%), Omeros Co. (24.41%), 2seventy bio, Inc. (14.59%), G1 Therapeutics, Inc. (5.41%), Foghorn Therapeutics Inc. (7.05%), Design Therapeutics, Inc. (9.06%), uniQure (6.72%), Puma Biotechnology, Inc. (8.96%), Immutep Limited (3.06%), Akebia Therapeutics, Inc. (5.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Pyxis Oncology stock? Short selling PYXS is an investing strategy that aims to generate trading profit from Pyxis Oncology as its price is falling. PYXS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pyxis Oncology? A short squeeze for Pyxis Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PYXS, which in turn drives the price of the stock up even further. How often is Pyxis Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PYXS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ALDX Short Interest Data OMER Short Interest Data TSVT Short Interest Data GTHX Short Interest Data FHTX Short Interest Data DSGN Short Interest Data QURE Short Interest Data PBYI Short Interest Data IMMP Short Interest Data AKBA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PYXS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research